Trial Profile
An open-label, single- and multiple-dose study to investigate the pharmacokinetics of MP-513 in healthy Chinese volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Jul 2017
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 06 Jul 2017 New trial record